Professional Documents
Culture Documents
•Saturasi O₂ menurun
Pneumonia
•Saturasi CO₂ Meningkat
FR: Rokok
Infeksi
Asidosis
respiratorik
Demam
Penurunan
Risiko u/ kesadaran
ARDS/COPD
Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM (eds). Fishman’s Manual of
Pulmonary Disease and Disorder 5th Edition. New York. Mc GrawHIll, 2015
Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM
(eds). Fishman’s Manual of Pulmonary Disease and
Disorder 5th Edition. New York. Mc GrawHIll, 2015
Diagnosa
• Imaging:
1. Chest X-ray(reveal either ARDS cause by cardiogenic or non-
cardiogenic, reveal how much fluid in your lung)
2. CT-scan.
• Lab tests
1. Arterial Blood Gas(ABG) -> reveal oxygen saturation to Hb
2. Sputum culture -> if suspect of infection
• Heart test
1. Electrocardiogram. -> diagnostic right side-heart hypertrophy
2. Echocardiogram -> reveal heart structure abnormalities
Management
• Supplemental oxygen -> milder symptoms or as a
temporary measure. Delivered through non-rebreathing
mask.
Tintinalli’s
Emergency Medicine
a Comprehensive
Study Guide 8th ed.
Treatment
• Oxygen : Administer oxygen to raise the Pao2
above 60 mm Hg or the Sao2 above 90%
• β2-Adrenergic Agonists
– Short-acting β2-agonists and anticholinergic agents
are first-line therapies in the management of acute,
severe COPD
– β2-Agonists are best given every 30 to 60 minutes if
tolerated
– Nebulized aerosols every 20 minutes may result in
more rapid improvement of FEV1, but more frequent
side effects (tremor, anxiety, and palpitations)
– Asymptomatic
– Detected only by a + screening TB skin test / by abnormalities on chest
radiograph
– Infeksi primer dan aktif : fever, malaise, weight loss, and chest pain
• Reactivation TB
– Latent reactivation : symptoms bisa sistemik / pulmonary
• Most common: similar to those of primary tuberculosis and include fever,
night sweats, malaise, fatigue, and weight loss
– Productive cough, hemoptysis, dyspnea, and pleuritic chest pain muncul pas
infeksinya ud nybar di dlm paru
– PF: unremarkable; rales may be noted in areas of pulmonary infection
– extrapulmonary site of TB: lymphatic system—painless lymphadenopathy (i.e.,
scrofula, cervical lymphadenitis).
• Include abdominal pain due to hepatosplenomegaly, peritoneal tubercles,
prostatitis, epididymitis, or orchitis; adrenal insufficiency; bone pain with
arthritis, osteomyelitis, or Pott’s disease (bony destruction, often in the spine);
hematuria and sterile puree; and meningitis.
• also cause pericarditis lead to tamponade and constrictive symptoms
Dx & DD
• DD: community acquired pneumonia
– Clue that suggest TB : hemoptysis, night sweats,
and weight loss.
– Chest radiograph: look carefully for upper lung
field involvement, fibrocalcific changes, pleural
capping, or a calcified Ghon complex.
• Classification:
Risk factors
Coma
Drinking large amounts of alcohol
General anesthesia
Poor Gag reflex
Old age
1) Immediate Hospitalization
Marx JA, Hockberger RS, Walls RM. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 8th Ed. 2014.
Pathophysiology
• Normal: small amount of fluid is secreted from the parietal
pleura pleural space absorbed by visceral pleural
microcirculation
• Any process that increases fluid production or decreased
fluid removal by the lymphatics accumulation in the
pleural space
• Pleural effusions are traditionally divided based on
mechanism:
– Exudative effusions: influenced by local factors; pleural disease
(usually inflammation or neoplasia) that results in active fluid
secretion or leakage with high protein content
– Transudative effusions: influenced by systemic factors; an
imbalance between hydrostatic (e.g., CHF) and oncotic (e.g.,
nephrotic syndrome) pressures, this imbalance results in the
production of an ultrafiltrate with low protein content across
the pleural membrane Tintinalli JE. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7 th Ed. 20
Harrison’s Principles of Internal Medicine. 18th Ed. Volume II. Chapter 263.
Clinical Features
• May be clinically silent or come to detection from:
– Symptoms of an underlying disease
– Volume of pleural fluid reaches 500 ml dyspnea on
exertion/at rest
– New/enlarging pleural effusion, viral pleuritis, pulmonary
infarction Development of inflammation and associated
pain with respiration
• Physical findings: percussion dullness and decreased
breath sounds, localized pleural friction rub
Tintinalli JE. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th Ed. 2011.
Harrison’s Principles of Internal Medicine. 18th Ed. Volume II. Chapter 263.
Diagnosis
• Thoracocentesis
• Chest radiography
• Ultrasound bedside thoracic ultrasound to guide
thoracocentesis
• CT scan
Marx JA, Hockberger RS, Walls RM. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 8th Ed. 2014.
Harrison’s Principles of Internal Medicine. 18th Ed. Volume II. Chapter 263.
Harrison’s Principles of Internal Medicine. 18th Ed. Volume II. Chapter 263.
Treatment
• In patients with large effusions urgent therapeutic
thoracentesis may stabilize respiratory or circulatory status
– Thoracocentesis under ultrasound guidance
– Drainage of 1.0 -1.5 ml in one session, if >1500 ml: reexpansion
pulmonary edema
– Contraindications for thoracocentesis: coagulopathy, other bleeding
disorders, pleural adhesions
• Patients with pleural empyema (gross pus or organisms on
Gram stain) require insertion of a chest tube to drain the
pleural space adequately & prevent the development of
loculations
• Pain relief for patients with significant pleuritic pain: NSAIDs,
opioid analgesia
Tintinalli JE. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th Ed. 2011.
Harrison’s Principles of Internal Medicine. 18th Ed. Volume II. Chapter 263.
Acute Pulmonary Edema
• Acute development of alveolar lung edema due to
one or more of the following :
– Elevation of hydrostatic pressure in the pulmonary
capillaries (left heart failure, mitral stenosis)
– Specific precipitants, resulting in cardiogenic pulmonary
edema in patients with previously compensated heart
failure or without previous cardiac history
– Increased permeability of pulmonary alveolar-capillary
membrane (non-cardiogenic pulmonary edema)
• Pulmonary edema occurs when fluid is filtered into
the lungs faster than it can be removed
• Accumulation of fluid may have major consequences
on lung function because efficient gas exchange
cannot occur in fluid-filled alveoli
• Non-cardiogenic pulmonary edema
Acute Pulmonary Direct injury to Lung
– Chest trauma, pulmonary contusion
– Aspiration
Edema – Smoke inhalation
– Pneumonia
• Cardiogenic pulmonary edema
– Left heart failure – Oxygen toxicity
– Mitral stenosis – Pulmonary embolism, reperfusion
– ACS with left heart failure Hematogenous Injury to Lung
– Arrhythmia – Sepsis
– Myocarditis – Pancreatitis
– Endocarditis – Nonthoracic trauma
– Cardiomyopathy – Multiple transfusion
– Pericardial Effusion – IV drug use, e.g heroin
– Crisis Hypertension – Cardiopulmonary bypass
– CKD Possible Lung Injury Plus Elevated
Hydrostatic Pressures
– High –altitude pulmonary edema
– Neurogenic pulmonary edema
– Reexpansion pulmonary edema
Acute Pulmonary Edema
Physical Finding
• Pt appears severely ill, often diaphoretic, sitting bolt
upright, tachypnea, and cyanosis
• Bilateral pulmonary rales (crackles), S3 gallop
• Frothy, blood-tinged sputum
Laboratory
• ABG reductions of both PaO2 and PaCO2 with
progression respiratory failure, hypercapnia develops with
academia
• CXR pulmonary vascular redistribution, diffuse haziness
in lung field with perihillar “butterfly” appearance
Acute Pulmonary Edema
Therapy
• Administer 100% O2 by mask to achieve PaO2 >60 mmHg; if
inadequate, use positive pressure ventilation by face or nasal
mask, and if necessary proceed to ETI
• Reduced preload :
– Seat upright to reduced venous return, if not hypotension
– IV loop diuretic (furosemide, initially 0.5-1 mg/kg); use lower dose
if does not take diuretic chronically)
– Nitroglycerin (sublingual 0.4 mg x 3 q5min) followed by 5-20
microgram/min IV if needed
– Morphine 2-4 mg IV; asses frequently for hypotension or
respiratory depression; naloxone should be available to reverse
effect of morphine if necessary
– Consider ACE-I if hypertension, or insetting of acute MI with HF
– Consider Nesiritide (2 microgram/kg bolus IV followed by 0.01
microgram/kg per min)for refractory symptoms – don’t use in
acute MI or cardiogenic shock
Acute Pulmonary Edema
Therapy
• Inotropic agent are indicated in cardiogenic
pulmonary edema and severe LV dysfunction
(dopamine, dobutamine, milrinone)
• The precipitating cause of non-cardiogenic or
cardiogenic pulmonary edema should be treated,
particularly acute arrhythmia or infection
• For refractory pulmonary edema associated with
persistent cardiac ischemia early coronary
revascularization
Acute Pulmonary Edema
Pneumothorax
Pneumothorax
• Occurs when free air enters the potential
space between the visceral and parietal
pleura.
• Classification:
1. Primary pneumothorax : occur without
clinically apparent lung disease
2. Secondary pneumothorax : occur in patients
with underlying lung disease.
•Saturasi O₂ menurun
Pneumonia
•Saturasi CO₂ Meningkat
FR: Rokok
Infeksi
Asidosis
respiratorik
Demam
Penurunan
Risiko u/ kesadaran
ARDS/COPD